Identification of PTSD in cancer survivors
Identification of PTSD in cancer survivors
复制标题
DOI：
10.1016/s0033-3182(96)71580-3
复制
发表时间：
1996-03-01
期刊：
影响因子：
3.4
通讯作者：
Kaplan, S
中科院分区：
文献类型：
--
作者：
Alter, CL;Pelcovitz, D;Kaplan, S
作者测量了一组癌症幸存者的创伤后应激障碍(PTSD)的发生率和决定因素。对确诊后至少3年内有癌症诊断史、没有接受过化疗或放疗等积极治疗的患者进行了访谈(N=27)。将参与DSM-IV创伤后应激障碍现场试验的患者与年龄和社会经济地位相匹配的社区控制组进行比较。存活组中有1名成员(4%)，对照组中没有成员符合当前创伤后应激障碍(NS)的标准。6名幸存者(22%)和没有对照的受试者符合终生标准(P<；0.02)。癌症患者的创伤后应激障碍的发生率比社区中发现的要高。症状与经历过其他创伤事件的人非常相似。
The authors measured the rate and determinants of posttraumatic stress disorder (PTSD) in a group Of cancer survivors. Patients who had a history of cancer diagnosis with at least 3 years since diagnosis, receiving no active treatment, such as chemotherapy or radiation, were interviewed (N = 27). Patients, who were part of the DSM-IV PTSD field trial, were compared with a community-based control group matched for age and socioeconomic status. One member of the survivor group (4%) and no members of the control group met criteria for current PTSD (NS). Six of the survivors (22%) and no control subjects met lifetime criteria (P < 0.02). Cancer patients have a higher rate of PTSD than found in the community. Symptoms closely resemble those of individuals who have experienced other traumatic events.